Liuyan Ding

568 total citations
25 papers, 383 citations indexed

About

Liuyan Ding is a scholar working on Neurology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Liuyan Ding has authored 25 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 11 papers in Neurology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Liuyan Ding's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Neuroinflammation and Neurodegeneration Mechanisms (10 papers) and Nuclear Receptors and Signaling (5 papers). Liuyan Ding is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Neuroinflammation and Neurodegeneration Mechanisms (10 papers) and Nuclear Receptors and Signaling (5 papers). Liuyan Ding collaborates with scholars based in China and United States. Liuyan Ding's co-authors include Yunlong Zhang, Wenlong Zhang, Junwei Gong, Mengran Zhang, Pingyi Xu, Huaqing Chen, Shaohui Zheng, Runfang Ma, Wenyuan Guo and Zhiling Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Journal of Hazardous Materials.

In The Last Decade

Liuyan Ding

25 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liuyan Ding China 12 137 118 94 84 70 25 383
Jiabin Tong China 10 119 0.9× 107 0.9× 99 1.1× 102 1.2× 39 0.6× 15 358
Huabao Liao China 11 196 1.4× 144 1.2× 56 0.6× 63 0.8× 86 1.2× 17 437
Chaojun Chen China 11 105 0.8× 105 0.9× 114 1.2× 45 0.5× 66 0.9× 32 422
Xiaoqin Zhu China 12 124 0.9× 65 0.6× 66 0.7× 50 0.6× 54 0.8× 27 323
Murad Al‐Nusaif China 12 157 1.1× 54 0.5× 58 0.6× 69 0.8× 47 0.7× 27 320
Shuxuan Huang China 12 184 1.3× 137 1.2× 174 1.9× 73 0.9× 74 1.1× 24 487
Xiao‐Liang Liu China 7 182 1.3× 47 0.4× 124 1.3× 72 0.9× 54 0.8× 10 405
Etrat Hooshmandi Iran 11 90 0.7× 70 0.6× 71 0.8× 71 0.8× 90 1.3× 39 365
Paulina Troncoso-Escudero Chile 7 173 1.3× 88 0.7× 98 1.0× 90 1.1× 35 0.5× 10 377
Tiziana Petrozziello Italy 14 181 1.3× 108 0.9× 116 1.2× 122 1.5× 96 1.4× 25 511

Countries citing papers authored by Liuyan Ding

Since Specialization
Citations

This map shows the geographic impact of Liuyan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liuyan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liuyan Ding more than expected).

Fields of papers citing papers by Liuyan Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liuyan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liuyan Ding. The network helps show where Liuyan Ding may publish in the future.

Co-authorship network of co-authors of Liuyan Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Liuyan Ding. A scholar is included among the top collaborators of Liuyan Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liuyan Ding. Liuyan Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Liuyan, Minshan Chen, Xiaobei Wang, et al.. (2025). Rhapontigenin attenuates neurodegeneration in a parkinson’s disease model by downregulating mtDNA-cGAS-STING-NF-κB-mediated neuroinflammation via PINK1/DRP1-dependent microglial mitophagy. Cellular and Molecular Life Sciences. 82(1). 337–337. 4 indexed citations
2.
Ding, Liuyan, Minshan Chen, Hui Shu, et al.. (2025). Biomass fuel induces neuroinflammation and neurodegeneration via the astrocyte-microglia IL-17A/IL-17RA pathway. Journal of Hazardous Materials. 494. 138569–138569. 1 indexed citations
3.
Zhang, Wenlong, Jinqi Ren, Liuyan Ding, et al.. (2024). Nanotherapeutic Approaches of Interleukin‐3 to Clear the α‐Synuclein Pathology in Mouse Models of Parkinson's Disease (Adv. Sci. 42/2024). Advanced Science. 11(42). 2 indexed citations
4.
Liu, Yan, Jian Ren, Wenlong Zhang, et al.. (2024). Astroglial membrane camouflaged Ptbp1 siRNA delivery hinders glutamate homeostasis via SDH/Nrf2 pathway. Biomaterials. 312. 122707–122707. 5 indexed citations
5.
Ding, Liuyan, Lin Lü, Shaohui Zheng, et al.. (2024). Usp14 deficiency removes α-synuclein by regulating S100A8/A9 in Parkinson’s disease. Cellular and Molecular Life Sciences. 81(1). 232–232. 7 indexed citations
6.
Guo, Lingling, Zhijie Liu, Dinglan Zuo, et al.. (2024). Monoacylglycerol acyltransferase-2 inhibits colorectal carcinogenesis in APCmin+/− mice. iScience. 27(7). 110205–110205. 3 indexed citations
7.
Zhang, Wenlong, Huaqing Chen, Liuyan Ding, et al.. (2023). Microglial targeted therapy relieves cognitive impairment caused by Cntnap4 deficiency. SHILAP Revista de lepidopterología. 3(3). 20220160–20220160. 16 indexed citations
8.
Lin, Yuwan, Miaomiao Zhou, Wenyuan Guo, et al.. (2023). Correlation of SV2C rs1423099 single nucleotide polymorphism with sporadic Parkinson's disease in Han population in Southern China. Neuroscience Letters. 813. 137426–137426. 3 indexed citations
9.
Zhang, Wenlong, Liuyan Ding, Huaqing Chen, et al.. (2023). Cntnap4 partial deficiency exacerbates α-synuclein pathology through astrocyte–microglia C3-C3aR pathway. Cell Death and Disease. 14(4). 285–285. 29 indexed citations
10.
Qiu, Jiewen, Shiyin Li, Yunxin Wang, et al.. (2023). Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson’s disease. Frontiers in Aging Neuroscience. 14. 1077738–1077738. 8 indexed citations
11.
Li, Huiting, Li‐Xia Peng, Yan Mei, et al.. (2023). TSPAN1 inhibits metastasis of nasopharyngeal carcinoma via suppressing NF-kB signaling. Cancer Gene Therapy. 31(3). 454–463. 1 indexed citations
12.
Liu, Zhi‐Jie, Lisheng Zheng, Chang‐Zhi Li, et al.. (2023). Correlated with better prognosis, CSTA inhibits metastasis of nasopharyngeal carcinoma cells via suppressing AKT signaling through promoting METTL3 degradation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(5). 166696–166696. 6 indexed citations
13.
Zhang, Wenlong, Liuyan Ding, Mengran Zhang, et al.. (2023). Dietary intake of α-ketoglutarate ameliorates α-synuclein pathology in mouse models of Parkinson’s disease. Cellular and Molecular Life Sciences. 80(6). 155–155. 16 indexed citations
14.
Tao, Kai, Mingshu Mo, Wenyuan Guo, et al.. (2022). Chaperone-mediated Autophagy Regulates Cell Growth by Targeting SMAD3 in Glioma. Neuroscience Bulletin. 38(6). 637–651. 5 indexed citations
15.
Zhang, Wenlong, Jie Huang, Feng Gao, et al.. (2022). Lactobacillus reuteri normalizes altered fear memory in male Cntnap4 knockout mice. EBioMedicine. 86. 104323–104323. 16 indexed citations
16.
Gong, Junwei, Wenlong Zhang, Liuyan Ding, et al.. (2021). 4,4′-Dimethoxychalcone regulates redox homeostasis by targeting riboflavin metabolism in Parkinson's disease therapy. Free Radical Biology and Medicine. 174. 40–56. 12 indexed citations
17.
Huang, Shuxuan, Yuwan Lin, Yànhuá Lǐ, et al.. (2021). Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impairment in MPTP-Induced Parkinson’s Disease Model. Frontiers in Pharmacology. 11. 618787–618787. 58 indexed citations
18.
Lin, Yuwan, Miaomiao Zhou, Wei Dai, et al.. (2021). Bone-Derived Factors as Potential Biomarkers for Parkinson’s Disease. Frontiers in Aging Neuroscience. 13. 634213–634213. 17 indexed citations
19.
Zhang, Wenlong, Junwei Gong, Liuyan Ding, et al.. (2020). Functional validation of a human GLUD2 variant in a murine model of Parkinson’s disease. Cell Death and Disease. 11(10). 897–897. 18 indexed citations
20.
Zhang, Wenlong, Miaomiao Zhou, Junwei Gong, et al.. (2020). CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes. Theranostics. 10(7). 3000–3021. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiabin Tong Breakdown of academic impact, for papers by Huabao Liao Breakdown of academic impact, for papers by Chaojun Chen Breakdown of academic impact, for papers by Xiaoqin Zhu Breakdown of academic impact, for papers by Murad Al‐Nusaif Breakdown of academic impact, for papers by Shuxuan Huang Breakdown of academic impact, for papers by Xiao‐Liang Liu Breakdown of academic impact, for papers by Etrat Hooshmandi Breakdown of academic impact, for papers by Paulina Troncoso-Escudero Breakdown of academic impact, for papers by Tiziana Petrozziello
Rankless by CCL
2026